We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Urinary NAG-Creatine Ratio Predicts Advanced Diabetic Kidney Disease

By LabMedica International staff writers
Posted on 03 Jan 2023
Print article
Image: The AU5800 fully automated biochemical analyzer (Photo courtesy of Beckman-Coulter)
Image: The AU5800 fully automated biochemical analyzer (Photo courtesy of Beckman-Coulter)

Diabetes is the leading cause of chronic kidney disease and end-stage kidney disease worldwide and becomes one of the biggest healthcare challenges of the 21st century. Microvascular complications have been identified as the common and major diabetic complications.

Diabetic Kidney Disease (DKD) typically manifests a progressive deterioration of kidney function, and the increased glomerular filtration rate (GFR), glomerular hypertrophy, and excretion of urinary albumin are the major indicators. Various urine proteins may exhibit significant differences in diagnostic, predictive, and prognostic power for DKD.

Medical Scientists at the Suzhou Medical College of Soochow University (Suzhou, China) retrospectively analyzed a total of 117 patients with type 2 DKD, 83 males and 34 females, aged 37–85 years, including early and advanced stages and their laboratory parameters were statistically assessed. The patients were divided into two groups: early (stages IIa and IIb) and advanced (stages III and IV) groups based on the pathological grading.

The urine in spot time and whole 24 hours was obtained, and the fasting venous blood of patients were collected in vacutainer tubes. A BC-7500 automatic hematological analyzer (Mindray Inc, Shenzhen, China) was used to analyze the white blood cell (WBC), neutrophil (NEU), and high sensitive C reactive protein (HS-CRP). Multiple biochemical indexes were measured, which included serum creatine (sCR), serum urea (sUR), cholesterol (CHOL), homocysteine (HCY), thyroid stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), fibrinogen (FIB), and d-dimer (D-D).

The levels of urinary creatinine, N-acetyl-β-d-glucosaminidase (NAG), total protein (PRO), microalbumin (MA), immunoglobulin G (IgG), transferrin (TFR), and α1-microglobulin (α1MG) in spot urine, and albumin excretion (UAE) in 24 hour urine were measured by the AU5800 fully automated biochemical analyzer (Beckman-Coulter, Brea, CA, USA). Urinary N-acetyl-β-d-glucosaminidase (NAG) and proteins to creatinine ratios were calculated to present as NAG/CR, PRO/CR, albumin to creatine ratio (ACR), IgG/CR, TFR/CR, and α1MG/CR.

The investigators reported that N-acetyl-β-d-glucosaminidase-creatine (NAG/CR) level in advanced DKD was statistically higher than that in early DKD, and there was a higher incidence of advanced DKD (72% versus 56%) and high odds ratio (OR: 3.917) of NAG/CR with ≥2.79 U/mmol compared with <2.79 U/mmol. NAG/CR ratio also showed a higher area under the ROC curve of 0.727 with a high sensitivity (0.75) and a moderate specificity (0.66) when 1.93 U/mmol was set as the optimal cutoff value. The adjusted-multivariable analysis revealed that NAG/CR had an OR of 1.021 and 2.223 based on a continuous and categorical variable, respectively, for risk of advanced DKD. Moreover, the prevalence of advanced DKD exhibited an increasing tendency by an increment of the trisector of NAG/CR.

The authors concluded that NAG/CR ratio is an independent predictor for advanced DKD in type 2 diabetes (T2D) patients, and it also can be used as a powerful identifying marker between early and advanced DKD. The study was published on December 26, 2022 in the Journal of Clinical Laboratory Analysis.

Related Links:
Suzhou Medical College of Soochow University
Mindray Inc 

Gold Supplier
Foam Tipped Applicator
PurSwab 5"
Semi-Automatic Biochemistry Analyzer
Silver Supplier
HSV1+2 / VZV Test
Savvygen HSV1+2 / VZV

Print article



view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more


view channel
Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

Every year worldwide, lung cancer afflicts over two million individuals and almost the same number of people succumb to the disease. This malignancy leads the charts in cancer-related mortalities, with... Read more


view channel
Image: The rapid MTB strip test for tuberculosis can identify TB patients within two hours (Photo courtesy of Chulalongkorn University)

Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through... Read more


view channel
Image: The UNIQO 160 (CE-IVDR) advances diagnostic analysis for autoimmune diseases (Photo courtesy of EUROIMMUN)

Novel Automated IIFT System Enables Cutting-Edge Diagnostic Analysis

A newly-launched automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics offers an all-in-one solution to enhance the efficiency of the complete IIFT process, comprising... Read more


view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more


view channel
Image: The global HbA1c testing devices market is expected to reach USD 2.56 billion in 2027 (Photo courtesy of Freepik)

Global Hemoglobin A1c Testing Devices Market Driven by Rising Prevalence of Diabetes

Hemoglobin A1c (HbA1c), or glycated hemoglobin, refers to hemoglobin with glucose attached. HbA1c testing devices are used for blood tests that determine average blood glucose, or blood sugar levels.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.